Profile for European Patent Office Patent: 1632232
✉ Email this page to a colleague
| Country | SPC | SPC Expiration |
|---|---|---|
| Netherlands | 300852 | ⤷ Start Trial |
| Netherlands | 300853 | ⤷ Start Trial |
| Lithuania | PA2016043 | ⤷ Start Trial |
| Lithuania | PA2016042 | ⤷ Start Trial |
| Denmark | CA 2016 00066 | ⤷ Start Trial |
| Denmark | CA 2016 00065 | ⤷ Start Trial |
| Germany | 122016000111 | ⤷ Start Trial |
US Patent Family Members and Approved Drugs for European Patent Office Patent: 1632232
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
